甲状腺手术围术期抗溃疡药使用分析

张强; 李健; 彭冉; 黎永娴; 张强; 李健; 彭冉; 黎永娴

doi:10.3969/j.issn.1006-0111.2016.03.020

[1]

中华医学杂志编辑委员会.应激性溃疡防治建议[J].中华医学杂志,2002,82(14):1000-1001.

[2]

ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis.ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998[J].Am J Health Syst Pharm,1999,56(4):347-379.

[3]

Bardou M, Barkun AN. Stress Ulcer Prophylaxis in the ICU:Who, When and How[J]. Crit Care Med,2013,41(3):906-907.

[4]

郭宁.外科治疗在甲状腺疾病中的应用研究[J].中国当代医学,2013,20(5):18-19.

[5]

Bez C, Perrottet N, Zingg T,et al. Stress ulcer prophylaxis in non-critically ill patients:a prospective evaluation of current practice in a general surgery department[J].J Eval Clin Pract,2013,19(2):374-378.

[6]

Heidelbaugh JJ, Inadomi JM.Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients[J].Am J Gastroenterol,2006,101(10):2200-2205.

[7]

王辉.276例外科手术使用PPIs预防应激性溃疡的用药分析[J]. 海峡药学, 2014,26(4):97-99.

[8]

Barkun A, Bardou M,Marshall JK.Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding[J]. Ann Intern Med, 2003,139:843-857.

[9]

李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639.

[10]

Barletta JF. Does histamine-2-receptor-antagonist administration lead to more gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock?[J].Ann Pharmacother, 2014,48(10):1276-1281.

[11]

Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis:clinical and economic consequences[J].Pharmacoeconomics,2014,32(1):5-13.

[12]

熊碧芳,刘小红,戴水田,等. 泰胃美针剂对烧伤病人细胞免疫的调节作用[J]. 中国现代医学杂志,1999,9(8):24-25.

[13]

陈继民,彭淑清. 雷尼替丁与腹部手术后细胞免疫功能的关系[J]. 中华实验外科杂志,1996,13(5):277.

[14]

晓峰,姚健凤,顾同进,等. 奥美拉唑不同途径、剂量给药抑制胃酸效果[J]. 中国新药与临床杂志,2001,20(4):302-303.

[15]

黄艳兰. 应激性溃疡危险因素预防循证指南[J]. 中国煤炭工业医学杂志, 2009,12(11):1825-1826.

[16]

金仙妹,王海燕,兰美娟,等. 危重病患者早期肠内营养预防应激性溃疡的观察与护理[J]. 中华护理杂志,2002,37(7):485-487.